CME Expiration Date: January 31, 2018
Activity Disclosures: Authors- None
Peer Reviewers- None
Commercial Support: None
You must be logged in and own this product in order to post comments.
Three-dimensional Echocardiography in Congenital Heart Disease: An Expert Consensus Document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography: CME Information
Release date: January 2017 Valid through: January 2018
Introduction/Statement of Need:
Three-dimensional echocardiography (3DE) has become important in the management of patients with congenital heart disease (CHD), particularly with pre-surgical planning, guidance of catheter intervention, and functional assessment of the heart. 3DE is increasingly used in children because of good acoustic windows and the non-invasive nature of the technique. The aim of this paper is to provide a review of the optimal application of 3DE in CHD including technical considerations, image orientation, and application to different lesions, procedural guidance, and functional assessment.
This activity is designed for all cardiac sonographers and cardiovascular physicians with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, intensivists, and other medical professionals with a specific interest in pediatric and congenital heart disease may find this activity beneficial.
After completing this activity, participants should be better able to:
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Echocardiography designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ARDMS, CCI and Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.
The American Society of Echocardiography is committed to ensuring that its educational mission and all sponsored educational programs are not influenced by the special interests of any corporation or individual, and its mandate is to retain only those authors whose financial interests can be effectively resolved to maintain the goals and educational integrity of the activity. While a monetary or professional affiliation with a corporation does not necessarily influence an author’s presentation, the Essential Areas and policies of the ACCME require that any relationships that could possibly conflict with the educational value of the activity be resolved prior to publication and disclosed to the audience. Disclosures of faculty and commercial support relationships, if any, have been indicated.
John Simpson, MBChB, MD, FESC, Leo Lopez, MD, FASE, Philippe Acar, MD, PhD,
Mark K. Friedberg, MD, FASE, Nee S. Khoo, MBChB, H. Helen Ko, BS, ACS, RDMS, RDCS, RCCS, FASE, Jan Marek, MD, PhD, FESC, Gerald Marx, MD, FASE, Jackie S. McGhie, Folkert Meijboom, MD, David Roberson, MD, FASE, Annemien Van den Bosch, MD, PhD, Owen Miller, BMed, and Girish Shirali, MBBS, FASE.
This activity received no commercial support.
According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.
The following authors reported no actual or potential conflicts of interest in relation to this document:
John Simpson, MBChB, MD, FESC, Leo Lopez, MD, FASE, Philippe Acar, MD, PhD, Mark K. Friedberg, MD, FASE, Nee S. Khoo, MBChB, H. Helen Ko, BS, ACS, RDMS, RDCS, RCCS, FASE, Jan Marek, MD, PhD, FESC, Gerald Marx, MD, FASE, Jackie S. McGhie, Folkert Meijboom, MD, David Roberson, MD, FASE, Annemien Van den Bosch, MD, PhD, Owen Miller, BMed, and Girish Shirali, MBBS, FASE.
The following board and guidelines and standards committee members reviewed this document and reported no actual or potential conflicts of interest in relation to this document:
Deborah A. Agler, RCT, RDCS, FASE, Merri L. Bremer, EdD, RN, EDCS, ACS, FASE, Benjamin Byrd, MD, FASE, Hollie D. Carron, RDCS, FASE, Frederick C. Cobey, MD, FASE, Patrick Collier, MD, PhD, FASE, Patrick D. Coon, RCCS, RDCS, FASE, Adam Dorfman, MD,FASE, Fadia Makarem Ezzeddine, RT, RCS, FASE, Craig Fleishman, MD, FASE, Yvonne E. Gilliland, MD, FASE, Aasha S. Gopal, MD, FASE, Lanqi Hua, RDCS, FASE, Joe R. Kreeger, ACS, RCCS, RDCS, FASE, Sunil Mankad, MD, FASE, Maryellen H. Orsinelli, RN, RDCS, FASE, Andy Pellett, PhD, RCS, RDCS, FASE, Patricia A. Pellikka, MD, FASE, SueD. Phillip, RCS, FASE, Juan Carlos Plana, MD, FASE, Michael Quartermain, MD, FASE, Vera H. Rigolin, MD, FASE, Brad J. Roberts, ACS, RCS, FASE, Vandana Sachdev, MD, FASE, Anita Sadeghpour, MD, FASE, Fadi Shamoun, MD, FASE, Elaine Shea, ACS, RCS, RCCS, FASE, Vincent L. Sorrell, MD, FASE, Cynthia Taub, MD, FASE, Neil J. Weissman, MD, FASE
The following board and guidelines and standards committee members reported relationships with one or more commercial interests:
Federico Asch, MD, FASE- Medtronic (Research Grant Support); St. Jude Medical (Research Grant Support); Biotronik (Research Grant Support); Sorin Group (Research Grant Support); Boston Scientific (Research Grant Support); Edwards Lifesciences (Research Grant Support); Abbott Vascular (Research Grant Support); Mitralign (Research Grant Support); Direct Flow (Research Grant Support); Xaltis (Research Grant Support)
Meryl Cohen, MD, FASE - Johnson & Johnson (Stock Ownership); Pfizer (Stock Ownership)
Stephen Heitner, MD, FASE- Johnson & Johnson (Stock Ownership); Millennium Pharmaceuticals (Consultant/ Advisor); Onyx pharmaceuticals (Consultant/ Advisor)
Soo Kim, MD, MPH, RPVI, FASE- Philips Ultrasound (Consultant/ Advisor)
Allan Klein, MD, FASE -Bayer (Steering Committee)
Stamatios Lerakis, MD, FASE- Edwards Lifesciences (Consultant/ Advisor)
Stephen Little, MD, FASE- St. Jude Medical (Research Grant Support); Abbott Structural (Research Grant Support); Medtronic (Research Grant Support)
Tasneen Naqvi, MD, FASE- Adagio Medical (Stock Ownership); Panasonic CardioHealth Station (Research Grant Support)
Lawrence Rudski, MD, FASE- GE (Stock Ownership)
Roman Sniecinski, MD, FASE- Grifols Therapeutics (Consultant/ Advisor)
Steven Walling, RCS, RDCS, FASE- Lantheus (Speaker/ Speakers Bureau) (Consultant/Advisor)
Susan Wiegers MD, FASE- Merck (Stock Ownership); Covance (Spouse Employment)
The following ACCME reviewers, ASE Staff and CME editors reported no actual or potential conflicts of interest in relation to this document:
Rebecca Hahn, MD, FASE, Timothy Slesnick, MD, FASE, Raymond Musarra RCS, RDCS, FASE, Rhonda Price, and Christina LaFuria
The following ACCME reviewers, ASE Staff and CME editors reported relationships with one or more commercial interests:
Method of Participation: Online Only
Estimated Time to Complete this Activity: 1 hour
Receiving CME Credit:
To receive online CME credit for this activity, read the full activity then complete the posttest and evaluation. A score of 70% or higher is required for successful completion. You will be able to print your CME certificate immediately following successful completion of the posttest and evaluation.
You will need a compatible browser like Mozilla FireFox, Google Chrome or safari to view the content. Internet Explorer may not work.
This report is made available by EACVI and ASE as a courtesy reference source for members. This report contains recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in this report are primarily based on the opinions of experts, rather than on scientifically verified data. EACVI and ASE make no express or implied warranties regarding the completeness or accuracy of the information in this report, including the warranty of merchantability or fitness for a particular purpose. In no event shall EACVI or ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by EACVI/ASE or create any physician–patient relationship between EACVI/ASE and your patients or anyone else.
Copyright American Society of Echocardiography. Questions? Contact us at email@example.com